Skip to main content
padlock icon - secure page this page is secure

Formulation, Optimization and Characterization of Self Nanoemulsifying Drug Delivery System (SNEDDS) of Paclitaxel for Solubility Enhancement

Buy Article:

$106.34 + tax (Refund Policy)

In the present study, self-nanoemulsifying drug delivery systems (SNEDDS) of paclitaxel were developed with the objectives of increasing its bioavailability by enhancing its solubility and diminishing P-glycoprotein drug efflux. Ternary phase diagrams were constructed to identify the efficient nanoemulsification regions. Selected formulations from phase diagram were evaluated for various parameters. Droplet size was found to be less than 20 nm with polydispersity index and zeta potential of 0.176 and –38.1 mV respectively.In vitro release study showed upto 99% drug release from SNEDDS in approximately 3 hour. The drug release from SNEDDS was dramatically enhanced compared with that of the suspension (P < 0.05). Thus the present study indicated great potential for enhancing the solubility of paclitaxel which may lead to enhanced bioavailability through oral administration.
No Reference information available - sign in for access.
No Citation information available - sign in for access.
No Supplementary Data.
No Article Media
No Metrics


Document Type: Research Article

Publication date: August 1, 2013

More about this publication?
  • Nanoscience and Nanotechnology Letters (NNL) is a multidisciplinary peer-reviewed journal consolidating nanoscale research activities in all disciplines of science, engineering and medicine into a single and unique reference source. NNL provides the means for scientists, engineers, medical experts and technocrats to publish original short research articles as communications/letters of important new scientific and technological findings, encompassing the fundamental and applied research in all disciplines of the physical sciences, engineering and medicine.
  • Editorial Board
  • Information for Authors
  • Subscribe to this Title
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more